Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019 May 6, 2019 01:30AM
Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting May 3, 2019 01:30AM
Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events Apr 29, 2019 01:30AM
Nicox First Quarter 2019 Business Update and Financial Highlights Apr 18, 2019 01:30AM
Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis Mar 19, 2019 02:31AM


Mar 15, 2019 02:31AM Nicox signs agreement for ZERVIATE in China for up to €17 million in milestone payments plus royalties